Yoga Impact in Fibromyalgia, Primary Health Care
- Conditions
- Fibromyalgia
- Registration Number
- NCT06646796
- Lead Sponsor
- University of Coimbra
- Brief Summary
This study aims to evaluate the effectiveness of a complementary therapy using Yoga within the scope of First Health Care in Portugal, in pain control, quality of life and well-being of the patients with Fibromyalgia. It also, pretends to assess the viability and to identify the barriers to this sort of therapy in the context of Primary Health Care.
- Detailed Description
Fibromyalgia is a chronic and debilitating pain syndrome characterized by widespread and persistent pain, also affecting sleep quality and cognitive function. It is estimated to affect 3.6% of the population; however, since it is a condition that is often underdiagnosed, the actual numbers may be higher. It is also an incurable disease, so treatment is based on symptom management through pharmacological therapy, which is not always effective. Due to the inadequacy of pharmacological therapy, there is a need for complementary therapies, and despite the limited number of studies conducted in this area, some therapies based on meditative movement (notably yoga) are beginning to emerge, with beneficial effects reported on pain management and quality of life in these patients. Therefore, this study aims to investigate the benefits and feasibility of this type of intervention at the Primary Health Care level.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 20
- Users of the Family Health Unit diagnosed with Fibromyalgia;
- With cognitive capacity to answer the questionnaire;
- With physical capacity to take part in Yoga classes.
- people under 18 years old.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Quality of Life at the beggining and up to 3 months EQ-5D
Pain at the beggining and up to 3 months Visual scale from 0 to 10 to measure pain
Global perception of change up to 3 months Patient Global Impression of Change scale (portuguese validated version)
1 to 7 (1 is the worst, 7 is the best)
- Secondary Outcome Measures
Name Time Method Well-being at the beggining and up to 3 months EADS-21
Benefits perceived up to 3 months Open question answered by the patients trough a written text
Difficulties perceived up to 3 months Open question answered by the patients trough a written text
Replicability and ease of introducing treatment in the context of the Portuguese national health service up to 3 months Open questions and SWOT analysis
Trial Locations
- Locations (1)
USF Coimbra Centro
🇵🇹Coimbra, Portugal